Il y a eu 50 transactions d'initiés récentes enregistrées pour Beam Therapeutics Inc. (BEAM), dont 20 achats et 29 ventes. Le total des achats d'initiés s'élève à $18.2M et le total des ventes d'initiés à $5.62M.
Les initiés notables ayant une activité récente comprennent Walsh Kathleen E, Evans John M., Ciaramella Giuseppe. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — BEAM
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2033-06-06 |
Walsh Kathleen E |
Director |
Attribution de RSU |
16,532 |
$34.33 |
$567.54K |
16,532 |
| 2026-04-01 |
Evans John M. |
CEO |
Vente Informative |
30,078 |
$24.58 |
$739.32K |
1,047,205 |
| 2026-04-01 |
Ciaramella Giuseppe |
President |
Vente Informative |
11,810 |
$24.58 |
$290.29K |
218,406 |
| 2026-04-01 |
Bellon Christine |
Chief Legal Officer |
Vente Informative |
5,956 |
$24.58 |
$146.4K |
109,711 |
| 2026-04-01 |
Simon Amy |
Chief Medical Officer |
Vente Informative |
6,700 |
$24.58 |
$164.69K |
102,735 |
| 2026-04-01 |
Cavanagh Bethany J |
SVP, Finance and Treasurer |
Vente Informative |
3,242 |
$24.58 |
$79.69K |
51,171 |
| 2026-03-31 |
Evans John M. |
CEO |
Exercice d'Options (Vente) |
25,000 |
$0.67 |
$16.75K |
18,672 |
| 2026-03-31 |
Ciaramella Giuseppe |
President |
Attribution de RSU |
40,000 |
- |
- |
230,216 |
| 2026-03-31 |
Emany Sravan Kumar |
Chief Financial Officer |
Attribution de RSU |
31,750 |
- |
- |
105,456 |
| 2026-03-31 |
Bellon Christine |
Chief Legal Officer |
Attribution de RSU |
20,000 |
- |
- |
115,667 |
| 2026-03-31 |
Simon Amy |
Chief Medical Officer |
Attribution de RSU |
31,750 |
- |
- |
109,114 |
| 2026-03-31 |
Cavanagh Bethany J |
SVP, Finance and Treasurer |
Attribution de RSU |
20,000 |
- |
- |
54,813 |
| 2026-03-30 |
Evans John M. |
CEO |
Exercice d'Options (Vente) |
25,000 |
$0.67 |
$16.75K |
43,672 |
| 2026-02-24 |
Ciaramella Giuseppe |
President |
Vente Informative |
35,000 |
$32.00 |
$1.12M |
190,216 |
| 2026-01-31 |
Evans John M. |
CEO |
Attribution de RSU |
180,000 |
$27.62 |
$4.97M |
180,000 |
| 2026-01-31 |
Ciaramella Giuseppe |
President |
Attribution de RSU |
80,000 |
$27.62 |
$2.21M |
80,000 |
| 2026-01-31 |
Emany Sravan Kumar |
Chief Financial Officer |
Attribution de RSU |
63,500 |
$27.62 |
$1.75M |
63,500 |
| 2026-01-31 |
Bellon Christine |
Chief Legal Officer |
Attribution de RSU |
40,000 |
$27.62 |
$1.1M |
40,000 |
| 2026-01-31 |
Simon Amy |
Chief Medical Officer |
Attribution de RSU |
88,500 |
$27.62 |
$2.44M |
88,500 |
| 2026-01-31 |
Cavanagh Bethany J |
SVP, Finance and Treasurer |
Attribution de RSU |
40,000 |
$27.62 |
$1.1M |
40,000 |
| 2026-01-30 |
Evans John M. |
CEO |
Exercice d'Options (Vente) |
25,000 |
$0.67 |
$16.75K |
68,672 |
| 2026-01-29 |
Evans John M. |
CEO |
Exercice d'Options (Vente) |
19,336 |
$0.67 |
$12.96K |
- |
| 2026-01-22 |
Bellon Christine |
Chief Legal Officer |
Vente Informative |
1,371 |
$34.00 |
$46.61K |
95,667 |
| 2026-01-22 |
Cavanagh Bethany J |
SVP, Finance and Treasurer |
Vente Informative |
6,198 |
$35.00 |
$216.93K |
34,813 |
| 2026-01-20 |
Cavanagh Bethany J |
SVP, Finance and Treasurer |
Vente Informative |
3,034 |
$30.12 |
$91.38K |
41,011 |
| 2026-01-15 |
Bellon Christine |
Chief Legal Officer |
Vente Informative |
559 |
$35.40 |
$19.79K |
97,038 |
| 2025-12-31 |
Emany Sravan Kumar |
Chief Financial Officer |
Vente Informative |
6,294 |
$27.10 |
$170.57K |
73,706 |
| 2025-12-31 |
Bellon Christine |
Chief Legal Officer |
Vente Informative |
1,254 |
$27.10 |
$33.98K |
115,667 |
| 2025-12-31 |
Simon Amy |
Chief Medical Officer |
Attribution de RSU |
12,500 |
- |
- |
77,364 |
| 2025-10-27 |
Fmr Llc |
10 Percent Owner, Other: See Remark 1 |
Vente Informative |
459 |
$26.68 |
$12.25K |
14 |
| 2025-10-06 |
Fmr Llc |
10 Percent Owner, Other: See Remark 1 |
Don (Donné) |
1,232,434 |
- |
- |
841,231 |
| 2025-10-02 |
Evans John M. |
CEO |
Exercice d'Options (Vente) |
25,000 |
$0.67 |
$16.75K |
19,336 |
| 2025-10-01 |
Evans John M. |
CEO |
Exercice d'Options (Vente) |
25,000 |
$0.67 |
$16.75K |
44,336 |
| 2025-10-01 |
Bellon Christine |
Chief Legal Officer |
Vente Informative |
373 |
$24.53 |
$9.15K |
116,921 |
| 2025-10-01 |
Cavanagh Bethany J |
SVP, Finance and Treasurer |
Vente Informative |
467 |
$24.53 |
$11.46K |
44,045 |
| 2025-07-30 |
Fmr Llc |
10 Percent Owner, Other: See Remark 1 |
Vente Informative |
48,374 |
$20.50 |
$991.67K |
2,073,665 |
| 2025-07-03 |
Simon Amy |
Chief Medical Officer |
Vente Informative |
876 |
$20.12 |
$17.63K |
64,864 |
| 2025-07-01 |
Simon Amy |
Chief Medical Officer |
Vente Informative |
374 |
$16.94 |
$6.34K |
65,740 |
| 2025-06-04 |
Maraganore John |
Director |
Attribution de RSU |
33,662 |
$17.15 |
$577.3K |
33,662 |
| 2025-06-04 |
Cooper Graham K |
Director |
Attribution de RSU |
33,662 |
$17.15 |
$577.3K |
33,662 |
| 2025-06-04 |
Walsh Kathleen E |
Director |
Attribution de RSU |
33,662 |
$17.15 |
$577.3K |
33,662 |
| 2025-06-04 |
Shaw Christi |
Director |
Attribution de RSU |
33,662 |
$17.15 |
$577.3K |
33,662 |
| 2025-06-04 |
Guindo Chirfi |
Director |
Attribution de RSU |
33,662 |
$17.15 |
$577.3K |
33,662 |
| 2025-06-04 |
Ho Carole |
Director |
Attribution de RSU |
33,662 |
$17.15 |
$577.3K |
33,662 |
| 2025-06-04 |
Fishman Mark |
Director |
Attribution de RSU |
33,662 |
$17.15 |
$577.3K |
33,662 |
| 2025-04-02 |
Simon Amy |
Chief Medical Officer |
Vente Informative |
20,997 |
$17.73 |
$372.29K |
65,742 |
| 2025-04-01 |
Evans John M. |
CEO |
Vente Informative |
30,663 |
$18.35 |
$562.68K |
986,249 |
| 2025-04-01 |
Ciaramella Giuseppe |
President |
Vente Informative |
7,434 |
$18.35 |
$136.42K |
190,216 |
| 2025-04-01 |
Bellon Christine |
Chief Legal Officer |
Vente Informative |
5,674 |
$18.35 |
$104.12K |
117,294 |
| 2025-04-01 |
Simon Amy |
Chief Medical Officer |
Vente Informative |
9,566 |
$18.35 |
$175.54K |
86,739 |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi
